You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bladder cancer, oncolytic adenovirus, intravesical therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)

Recruiting
  • Bladder Cancer
  • H101, Camrelizumab
  • Hangzhou, Zhejiang, China
    Hua Wang
Oct 2, 2022

Non-muscle-invasive Bladder Cancer Trial in Beijing (OH2 injection)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • OH2 injection
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jul 12, 2022

Urinary Bladder Cancer Trial in Tucson (Gemcitabine)

Not yet recruiting
  • Urinary Bladder Cancer
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 21, 2022

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Bacillus Calmette Guerin With Use of Different Types of Urinary

Completed
  • Non-muscle-invasive Bladder Cancer
  • Marathon, Attica, Greece
    Themistoklis Bellos
Jan 10, 2023

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

Lower Urinary Tract Symptoms, Intravenous Drug Usage, Bladder Cancer Trial in Taipei (JING SI HERBAL TEA, Placebo)

Enrolling by invitation
  • Lower Urinary Tract Symptoms
  • +3 more
  • JING SI HERBAL TEA
  • Placebo
  • Taipei, Taiwan
    Buddhist Tzu Chi General Hospital, Taipei branch
Feb 20, 2023

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Non-muscle Invasive Bladder Cancer Trial in Aarhus (Urodynamic examination)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • Urodynamic examination
  • Aarhus, Denmark
    Aarhus University Hospital
Aug 5, 2022

Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)

Recruiting
  • Advanced Bladder Carcinoma
  • OH2 injection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022

Bladder Cancer Trial in Mansoura (Intravesical Bcg, Intravesical chemo (epirubicin))

Recruiting
  • Bladder Cancer
  • Intravesical Bcg
  • Intravesical chemotherapy (epirubicin)
  • Mansoura, DK, Egypt
    Mansoura Urology and Nephrology Center
Dec 21, 2021

Bladder Cancer Trial in Edmonton (High-Intensity Interval Training)

Recruiting
  • Bladder Cancer
  • High-Intensity Interval Training
  • Edmonton, Alberta, Canada
    Fernanda Zane Arthuso
Feb 15, 2022

Bladder Cancer Trial in Atlanta (Genistein, Sugar pill)

Active, not recruiting
  • Bladder Cancer
  • Atlanta, Georgia
  • +2 more
Dec 5, 2022

Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Active, not recruiting
  • Prostate Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022

Metastatic Melanoma Trial in Copenhagen, Nantes (TILT-123)

Recruiting
  • Metastatic Melanoma
  • TILT-123
  • Copenhagen, Denmark
  • +1 more
Dec 17, 2021

Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +5 more
  • Acupuncture Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 27, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

    Terminated
    • Transitional Cell Carcinoma
    • +3 more
    • CG0070 Adenovirus Vector
    • Control Arm: Quadruple Choice
    • Phoenix, Arizona
    • +6 more
    Apr 12, 2021

    Bladder Cancer Trial in United States (CG0070)

    Completed
    • Bladder Cancer
    • CG0070
    • Anchorage, Alaska
    • +16 more
    Apr 12, 2021

    Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and

    Recruiting
    • Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
    • TLD-1433 Bladder infusion and Photodynamic Therapy
    • Bala-Cynwyd, Pennsylvania
    • +10 more
    May 6, 2022

    Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

    Completed
    • Metastatic Pancreatic Cancer
    • Ad5-yCD/mutTKSR39rep-hIL12
    • Detroit, Michigan
      Henry Ford Hospital
    Feb 15, 2022

    Non-muscle Invasive Bladder Cancer Trial in United States (2141-V11)

    Recruiting
    • Non-muscle Invasive Bladder Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Dec 7, 2022

    Bladder Cancer Trial in Germany, Switzerland (VPM1002BC)

    Active, not recruiting
    • Bladder Cancer
    • Freiburg, Germany
    • +15 more
    Feb 3, 2022